Oncogenex Pharmaceuticals
Get Full AccessDescription
- OncoGenex is a leader in the development of novel therapeutics that target important mechanisms of treatment resistance in cancer. We are committed to the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
-
Headquarters:1522 217th Place Southeast Suite 100, Bothell, Washington, United States
More -
Phone Number: +1 425-686-1500
-
Website: https://www.oncogenex.com
-
Employees:18
-
Revenue:$10 - 50M
-
Legal Name:Oncogenex Pharmaceuticals
-
Oncogenex Pharmaceuticals's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Oncogenex Pharmaceuticals
-
Where are Oncogenex Pharmaceuticals's Headquarters?
Oncogenex Pharmaceuticals's Headquarters are in 1522 217th Place Southeast Suite 100,Bothell,Washington,United States
-
What is Oncogenex Pharmaceuticals's phone number?
Oncogenex Pharmaceuticals's phone number is +1 425-686-1500
-
What is Oncogenex Pharmaceuticals's official website?
Oncogenex Pharmaceuticals's official website is https://www.oncogenex.com
-
What is Oncogenex Pharmaceuticals's Revenue?
Oncogenex Pharmaceuticals's revenue is $10 - 50M
-
What is Oncogenex Pharmaceuticals's NAICS code?
Oncogenex Pharmaceuticals's NAICS code is 541715
-
How many employees are working in Oncogenex Pharmaceuticals
Oncogenex Pharmaceuticals has 18 employees
-
What is Oncogenex Pharmaceuticals's Industry?
Oncogenex Pharmaceuticals is in the industry of Biotechnology
-
Who is Oncogenex Pharmaceuticals's Vice President - Preclinical Development?
Oncogenex Pharmaceuticals's Vice President - Preclinical Development is Dean Kessler